Abstract
In debates about genetic testing of children, as well as about disclosing unsolicited findings (UFs) of pediatric exome sequencing, respect for future autonomy should be regarded as a prima facie consideration for not taking steps that would entail denying the future adult the opportunity to decide for herself about what to know about her own genome. While the argument can be overridden when other, morally more weighty considerations are at stake, whether this is the case can only be determined in concrete cases. Importantly, when children grow into adolescents, respect for future autonomy will have to give way to respecting their emerging autonomy. When pediatric exome sequencing is done for complex conditions not involving developmental delay, respect for the child’s future or emerging autonomy should be a primary consideration for those charged with deciding on behalf of the child. Building on what Emanuel and Emanuel have termed the ‘deliberative model’ of shared decision making, we argue that if parents fail to give these considerations their due, professionals should actively invite them to do so. Taking a directive stance may be needed in order to make sure that the future or emerging autonomy of the child are duly considered in the decision-making process, but also to help the parents and themselves to shape their respective roles as responsible care-givers.
Similar content being viewed by others
Notes
Findings unrelated to the reason for testing occur in all branches of medicine. They are often called ‘incidental findings’ (IFs). However, ‘incidental’ might suggest that such findings are rare, which is certainly not the case in clinical genomics. For this reason, the European Society of Human Genetics (ESHG) regards ‘unsolicited findings’ (UFs) as the more appropriate term in this context. [39] Conceptually, UFs (or IF)s are to be distinguished from so-called ‘Secondary findings’ (SFs). Although the latter also refer to results unrelated to the original reason for testing, SFs are actively sought for, whereas UFs are not. [30] It should be noted that both with regard to UFs and SFs, there is a risk of overdiagnosis, resulting from the fact that current predictivity data for the variants in question derive from evidence generated in affected families, whereas UFs or SFs are found in unaffected individuals [38].
For an early dissenting voice see the contribution to this debate by Stephen Robertson and Julian Savulescu in their 2001 Bioethics paper [32].
In their paper, Emanuel and Emanuel discuss two further models: the ‘informative’ and the ‘paternalistic’ model of the clinical relationship. In the former of these two, the professional limits herself to providing factual information, leaving it entirely to the patient to come to a decision; in the latter, the professional already knows what the best decision should be, and encourages the patient to consent to it. As there is no trace of shared decision making worth the name in either of these two models on the extremes of the 4-model spectrum, they are not relevant for our discussion.
References
ACMG Board of Directors. (2015). ACMG policy statement: Updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genetics in Medicine, 17(1), 68–69.
American Academy of Pediatrics. (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107(6), 1451–1455.
Academy of Pediatrics and American College of Medical Genetics. (2013). Ethical and policy issues in genetic testing and screening of children. Pediatrics, 131(3), 620–622.
Bertier, G., Senecal, K., Borry, P., & Vears, D. F. (2017). Unsolved challenges in pediatric whole-exome sequencing: A literature analysis. Critical Reviews in Clinical Laboratory Sciences, 54(2), 134–142.
Bloch, M., & Hayden, M. R. (1990). Predictive testing for Huntington disease in childhood—Challenges and implications—Opinion. American Journal of Human Genetics, 46(1), 1–4.
Borry, P., G. Evers-Kiebooms, M. C. Cornel, A. Clarke, K. Dierickx, Public, and Genetics Professional Policy Committee of the European Society of Human. (2009). Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. European Journal of Human Genetics, 17(6), 711–719.
Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clinical Genetics, 70(5), 374–381.
Botkin, J. R. (2016). Ethical issues in pediatric genetic testing and screening. Current Opinion in Pediatrics, 28(6), 700–704.
Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., et al. (2015). Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 97(1), 6–21.
Bredenoord, A. L., de Vries, M. C., & van Delden, J. J. (2013). Next-generation sequencing: Does the next generation still have a right to an open future? Nature Reviews Genetics, 14(5), 306.
Carmichael, N., Tsipis, J., Windmueller, G., Mandel, L., & Estrella, E. (2015). “Is it going to hurt?” The impact of the diagnostic odyssey on children and their families. Journal of Genetic Counseling, 24(2), 325–335.
Clarke, A. (1994). The genetic testing of children. Journal of Medical Genetics, 31(10), 785–797.
Clarke, A., & Flinter, F. (1996). The genetic testing of children: A clinical perspective. In T. Marteau & M. Richards (Eds.), The troubled helix: social and psychological implications of ther new human genetics (pp. 164–176). Cambridge: Cambridge University Press.
Clarke, A. J. (2014). Managing the ethical challenges of next-generation sequencing in genomic medicine. British Medical Bulletin, 111(1), 17–30.
Clayton, E. W., McCullough, L. B., Biesecker, L. G., Joffe, S., Ross, L. F., & Wolf, S. M. (2014). Addressing the ethical challenges in genetic testing and sequencing of children. The American Journal of Bioethics, 14(3), 3–9.
Cornelis, C., Tibben, A., Dondorp, W., van Haelst, M., Bredenoord, A. L., Knoers, N., et al. (2016). Whole-exome sequencing in pediatrics: Parents’ considerations toward return of unsolicited findings for their child. European Journal of Human Genetics, 24(12):1681–1687.
Coughlin, K. W. (2018). Medical decision-making in paediatrics: Infancy to adolescence. Paediatr Child Health, 23(2), 138–146.
Davis, D. S. (2010). Genetic Dilemma’s. Reproductive Technology, parental choices, and children’s futures (2nd ed.). New York: Oxford University Press.
Dondorp, W., Sikkema-Raddatz, B., de Die-Smulders, C., & de Wert, G. (2012). Arrays in postnatal and prenatal diagnosis: An exploration of the ethics of consent. Human Mutation, 33(6), 916–922.
Elwyn, G., Frosch, D., Thomson, R., Joseph-Williams, N., Lloyd, A., Kinnersley, P., et al. (2012). Shared decision making: A model for clinical practice. Journal of General Internal Medicine, 27(10), 1361–1367.
Emanuel, E. J., & Emanuel, L. L. (1992). Four models of the physician-patient relationship. JAMA, 267(16), 2221–2226.
European Society of Human Genetics. (2009). Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. European Journal of Human Genetics, 17(6), 720–721.
Garrett, J. R., Lantos, J. D., Biesecker, L. G., Childerhose, J. E., Chung, W. K., Holm, I. A., et al. (2019). Rethinking the “open future” argument against predictive genetic testing of children. Genetics in Medicine, 21(10), 2190–2198.
Gerrits, T., Reis, R., Braat, D. D., Kremer, J. A., & Hardon, A. P. (2013). Bioethics in practice: Addressing ethically sensitive requests in a Dutch fertility clinic. Social Science and Medicine, 98, 330–339.
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574.
Holm, I. A., Savage, S. K., Green, R. C., Juengst, E., McGuire, A., Kornetsky, S., et al. (2014). Guidelines for return of research results from pediatric genomic studies: deliberations of the Boston Children’s Hospital Gene Partnership Informed Cohort Oversight Board. Genetics in Medicine, 16(7), 547–552.
Kalia, S. S., Adelman, K., Bale, S. J., Chung, W. K., Eng, C., Evans, J. P., et al. (2017). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 19(2), 249–255.
Leyland, R., M. Heath, H. Neve, & V. Maynard. (2020). Structured refection on shared decision making. The Clinical Teacher, 17, 1–7.
Newson, A. J., & Schonstein, L. (2016). Genomic testing in the paediatric population: Ethical considerations in light of recent policy statements. Molecular diagnosis & therapy, 20(5), 407–414.
Ormond, K. E., O’Daniel, J. M., & Kalia, S. S. (2019). Secondary findings: How did we get here, and where are we going? Journal of Genetic Counseling, 28(2), 326–333.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., et al. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–424.
Robertson, S., & Savulescu, J. (2001). Is there a case in favour of predictive genetic testing in young children? Bioethics, 15(1), 26–49.
Ross, L. F., & Clayton, E. W. (2019). Ethical issues in newborn sequencing research: The case study of BabySeq. Pediatrics, 144(6), e20191031. https://pubmed.ncbi.nlm.nih.gov/31719124/.
Sandman, L., & Munthe, C. (2010). Shared decision making, paternalism and patient choice. Health Care Analysis, 18(1), 60–84.
Schupmann, W., Jamal, L., & Berkman, B. E. (2020). Re-examining the ethics of genetic counselling in the genomic era. Journal of Bioethical Inquiry, 17(3), 325–335.
Senecal, K., Rahimzadeh, V., Knoppers, B. M., Fernandez, C. V., Avard, D., & Sinnett, D. (2015). Statement of principles on the return of research results and incidental findings in paediatric research: A multi-site consultative process. Genome, 58(12), 541–548.
Tibben, A., Dondorp, W., Cornelis, C., Knoers, N., Brilstra, E., van Summeren, M., et al. (2020). Parents, their children, whole exome sequencing and unsolicited findings: Growing towards the child’s future autonomy. European Journal of Human Genetics (accepted for publication).
Turner, H., & Jackson, L. (2020). Evidence for penetrance in patients without a family history of disease: A systematic review. European Journal of Human Genetics, 28(5), 539–550.
van El, C. G., Cornel, M. C., Borry, P., Hastings, R. J., Fellmann, F., Hodgson, S. V., et al. (2013). Whole-genome sequencing in health care: Recommendations of the European Society of Human Genetics. European Journal of Human Genetics, 21(6), 580–584.
Wakefield, C. E., Hanlon, L. V., Tucker, K. M., Patenaude, A. F., Signorelli, C., McLoone, J. K., & Cohn, R. J. (2016). The psychological impact of genetic information on children: A systematic review. Genetics in Medicine, 18(8), 755–762.
Wilfond, B., & Ross, L. F. (2009). From genetics to genomics: Ethics, policy, and parental decision-making. Journal of Pediatric Psychology, 34(6), 639–647.
Wilfond, B. S., Pelias, M. Z., Knoppers, B. M., Reilly, P. R., Wertz, D. C., Billings, P., et al. (1995). Points to consider—Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 57(5), 1233–1241.
Funding
This research was funded by ZonMw—the Netherlands Organization for Health Research and Development (Grant No. 70-73000-98-047).
Author information
Authors and Affiliations
Contributions
All authors contributed to the design of the paper; a first draft was written by WD; IB, AT and GdW revised it for important intellectual content. All authors approved of the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dondorp, W., Bolt, I., Tibben, A. et al. ‘We Should View Him as an Individual’: The Role of the Child’s Future Autonomy in Shared Decision-Making About Unsolicited Findings in Pediatric Exome Sequencing. Health Care Anal 29, 249–261 (2021). https://doi.org/10.1007/s10728-020-00425-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10728-020-00425-7